SQZ Biotechnologies Company (SQZB)
OTCMKTS · Delayed Price · Currency is USD
0.0240
0.00 (0.00%)
Feb 25, 2026, 9:30 AM EST
SQZB Market Cap
SQZB has a market cap or net worth of $707.79 thousand as of February 26, 2026. Its market cap has decreased by -51.76% in one year.
Market Cap
707.79K
Enterprise Value
n/a
Revenue
12.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since October 30, 2020, SQZB's market cap has decreased from 317.63M to 707.79K, a decrease of -99.78%. That is a compound annual growth rate of -68.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 707.79K | - |
| Dec 31, 2025 | 707.79K | -20.00% |
| Dec 31, 2024 | 884.73K | 50.75% |
| Dec 29, 2023 | 586.87K | -97.31% |
| Dec 30, 2022 | 21.79M | -91.30% |
| Dec 31, 2021 | 250.64M | -65.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emmaus Life Sciences | 982.64K |
| Avenue Therapeutics | 922.50K |
| Protagenic Therapeutics | 867.55K |
| EV Biologics | 840.53K |
| Lipella Pharmaceuticals | 785.54K |
| Aibotics | 666.21K |
| Altamira Therapeutics | 651.56K |
| Bio-Path Holdings | 644.18K |